PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 17, 2026Lipids in Health and Disease0 citationsOpen Access

Association of apolipoprotein B and excess apolipoprotein B with cardiovascular risk in type 2 diabetes: a prospective cohort study of the UK Biobank

View Full Paper
LLLijuan LyuCKChunyu KaoJSJin Su

Key Points

  • The research aims to explore the relationship between apolipoprotein B levels and cardiovascular risk in individuals with type 2 diabetes.
  • Prospective cohort study design utilizing UK Biobank data.
  • Assessment of apolipoprotein B levels in participants with type 2 diabetes.
  • Evaluation of cardiovascular outcomes related to apolipoprotein B and excess apolipoprotein B.
  • Apolipoprotein B is independently linked to atherosclerotic cardiovascular disease risk in type 2 diabetes.
  • Excess apolipoprotein B showed enhanced risk discrimination compared to conventional lipid measures.
  • Clinical applicability of excess apolipoprotein B needs further validation and standardization for practical use.

Abstract

In T2DM, apoB is independently associated with ASCVD but adds limited discrimination over conventional lipids. Excess apoB yielded improved discrimination and reclassification, and may serve as a complementary ASCVD risk marker, particularly in statin-treated settings. However, its clinical application requires external validation and standardization.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lyu et al. (2026) studied this question.

synapsesocial.com/papers/696b2696d2a12237a9349ddbhttps://doi.org/10.1186/s12944-025-02852-8
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention2024 · 105 citations
  2. 2Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study2024 · 8 citations
  3. 3Non-HDL Cholesterol and Apolipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes2004 · 239 citations
  4. 4SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe2023 · 335 citations
  5. 5Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes2017 · 1,409 citations